masthead



                                         

Program 1 of 3 Scroll down to see them all.

This program provides brand name medications at no or low cost.
Pharmaceutical Company Amgen, Inc.
Program Name Safety Net Foundation
Program Address PO Box 13185
La Jolla, CA 92039
Phone Number

888-762-6436

Fax Number 866-549-7239
Medications on Program Aranesp Injection 1 (darbepoetin alfa)
Application Forms Safety Net Foundation Facility Application
Safety Net Foundation Replacement Form- Aranesp, Neulasta, Neupogen, Epogen, Vectibix
Safety Net Foundation Patient Application
Safety Net Foundation Attestation Form
Safety Net Foundation Notarized Income Statement
Safety Net Foundation Prescription Form- Senispar and Nplate
Safety Net Foundation Facility Application (Spanish)
Safety Net Foundation Replacement Form- Aranesp, Neulasta, Neupogen, Epogen, Vectibix (Spanish)
Safety Net Foundation Patient Application (Spanish)
Safety Net Foundation Attestation Form (Spanish)
Safety Net Foundation Notarized Income Statement (Spanish)
Safety Net Foundation Prescription Form- Senispar and Nplate (Spanish)
On-line Application
No on-line application available at this time
Web Site Click to go to program's web site
Eligibility Guidelines and Notes

The patient must have no insurance. meet income guidelines that are not disclosed.  The patient must also reside in the US. For those products administered pursuant to a physician office visit (including Aranesp, Epogen, Neupogen, Neulasta, and Vectibix), patients are enrolled through their provider (physician office or hospital facility). The provider must complete a Sponsor Enrollment Form (Form A) and will also facilitate completion of the Patient Enrollment Form (Form B). These medicines are on a replacement basis, so Form C (Product Request Form- Replacement) should be used. For Sensipar and Nplate, patients can enroll directly with The Safety Net Foundation by completing the Patient Enrollment Form (Form B) and Form C (Prescription Form- Prospective)

Application Process

The doctor or patient can call to request an application. The application will be faxed out. The completed application must be faxed back.  The doctor is notified of acceptance or denial.  The medication is sent within 30 days of acceptance.

Application Requirements

The doctor must fill out a section and sign the application. The patient must also complete, sign the application and attach proof of income.

Program Details

Up to a 30-day supply is sent to the doctor's office.  Once a year a new application with financial documentation is needed.

Last Updated May 07, 2010


                                         

Program 2 of 3 Scroll down to see them all.

This program provides help in applying for assistance with the cost of this drug.
Pharmaceutical Company Diplomat Specialty Pharmacy
Program Name Diplomat's Co-Pay Assistance Navigator Program
Program Address Attn: Funding Department
2029 S. Elms Rd., Suite D,
Swartz Creek, MI 48473
Phone Number

877-977-9118 ext. 10184

Fax Number 866-418-2650
Medications on Program Aranesp Injection 25mcg/ml, 40mcg/ml, 60mcg/ml, 100mcg/ml, 200mcg/ml, 300mcg/ml, 4500mcg/ml (darbepoetin alfa)
Application Forms Not Applicable
On-line Application
No on-line application available at this time
Web Site Click to go to program's web site
Eligibility Guidelines and Notes

Individual eligibility and level of financial support is determined on a case by case basis.  Medical diagnosis necessary for this program is not specified. US residency requirements are not specified. The Co-Pay Navigator is a full service program to help patients seek funding assistance for the co-pay portion of their required medications. There is no charge for this service. Physicians/physicians' offices may submit an application online at the website indicated above, or fax information as directed below.

Application Process

The physician/physician's office should fax the prescription, diagnosis, patient demographics and any insurance information to 866-418-2650 Attn: Sandy/Funding.  A Patient Care Coordinator will contact the patient within 24-48 business hours.     

Application Requirements

Will be discussed with the patient and physician after the initial request to the program is received. 

Program Details

Not applicable.

Last Updated May 07, 2010


                                         

Program 3 of 3.

This company does not offer a patient assistance program.
Pharmaceutical Company HealthWell Foundation
Program Name HealthWell Foundation Copay Program
Program Address P.O Box 4133
Gaithersburg, MD 20878
Phone Number

800-675-8416

Fax Number 800-282-7692
Medications on Program Aranesp Injection 1 (darbepoetin alfa)
Application Forms Not Applicable
On-line Application
No on-line application available at this time
Web Site Click to go to program's web site
Eligibility Guidelines and Notes

Applicants with insurance are eligible. The Foundation considers an individual's financial, medical, and insurance situation when determining who is eligible for assistance. Families with incomes below 400% of the Federal Poverty Level may qualify. Cost of living in a particular city or state is also taken into account. Medication must be used for medically appropriate condition. The patient must also reside in the US. This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.

Application Process

Anyone can call to get the application sent out or it may be completed online. The application is sent out or it may be completed online.     

Application Requirements

Not applicable.

Program Details

Not applicable.

Last Updated April 28, 2010